DT
HealthMore in Health→
FDA Grants Breakthrough Status to Blood Test That Tells Bacteria from Virus
Key Takeaways
- MeMed BV Flex measures a three-protein immune signature (TRAIL, IP-10, CRP) that distinguishes bacterial from viral infection
- FDA Breakthrough Device designation commits the agency to expedited interactive review and senior staff involvement
- Reducing inappropriate antibiotic prescriptions directly counters antimicrobial resistance, which causes 1.27 million deaths per year
- The test targets the majority of primary care antibiotic prescriptions, which are predominantly for viral respiratory infections
DE
DT Editorial Team··via medicalxpress.com